Skip to Main Content

Jennifer Doudna, who was awarded the Nobel Prize in Chemistry on Wednesday morning, along with collaborator Emmanuelle Charpentier, joined STAT at a San Francisco event last June when announcing a collaboration with the drug maker GlaxoSmithKline.

The collaboration between University of California, Berkeley, where Doudna is a professor, UC San Francisco, and GSK is to involve up to $67 million over five years. In the video below, Doudna and others talk about the relationship between researchers and drug companies, and the role that CRISPR, a gene-editing enzyme, will play in pharmaceutical research.

STAT reporter Matthew Herper talks with Jennifer Doudna, Hal Barron, and Jonathan Weissman about teaming up to use CRISPR technology in research for new medicines.

Comments are closed.